Scynexis (SCYX) Non-Current Assets (2013 - 2026)

Scynexis (SCYX) posted Non-Current Assets of $14.9 million for Q1 2026, down 19.93% on a QoQ basis from $18.7 million in Q4 2025, and down 4.84% year-over-year from $15.7 million in Q1 2025.

Scynexis (SCYX) Non-Current Assets (2013 - 2026) Analysis & Trends

Scynexis' Non-Current Assets history runs 14 years deep, the most recent figure standing at $14.9 million for Q1 2026.

  • Quarterly Non-Current Assets fell 4.84% year-over-year to $14.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.2 million (down 39.11% YoY) and the FY2025 annual result came in at $18.7 million, up 1.03% from the prior year.
  • Non-Current Assets was $14.9 million for Q1 2026 at Scynexis, down from $18.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $26.3 million in Q4 2023 and bottomed at $2.4 million in Q3 2025.
  • A 5-year average of $13.3 million and a median of $13.2 million in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Non-Current Assets jumped 200.56% — and 2025, when it slumped 87.2%.
  • Scynexis' Non-Current Assets stood at $8.7 million in 2022, then soared by 200.56% to $26.3 million in 2023, then retreated by 29.79% to $18.5 million in 2024, then increased by 1.03% to $18.7 million in 2025, then slipped by 19.93% to $14.9 million in 2026.
  • Business Quant data shows SCYX's Non-Current Assets at $14.9 million in Q1 2026, $18.7 million in Q4 2025, and $2.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Scynexis 21.55 Mn -15.20 Mn - 14.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.94 Mn
Dec 31, 2025 18.65 Mn
Sep 30, 2025 2.38 Mn
Jun 30, 2025 4.20 Mn
Mar 31, 2025 15.69 Mn
Dec 31, 2024 18.46 Mn
Sep 30, 2024 18.58 Mn
Jun 30, 2024 13.23 Mn
Mar 31, 2024 16.58 Mn
Dec 31, 2023 26.30 Mn
Sep 30, 2023 19.91 Mn
Jun 30, 2023 9.33 Mn
Mar 31, 2023 10.53 Mn
Dec 31, 2022 8.75 Mn
Sep 30, 2022 8.73 Mn
Jun 30, 2022 9.94 Mn
Mar 31, 2022 9.66 Mn
Dec 31, 2021 10.46 Mn
Sep 30, 2021 5.95 Mn
Jun 30, 2021 5.50 Mn